The influence of some cardioactive drugs on the energy-dependent uptake of calcium, potassium and adenine nucleotides by mitchondria.
D000227:Adenine Nucleotides / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D002118:Calcium / Q000032:analysis / Q000378:metabolism*; D003864:Depression, Chemical; D006863:Hydrogen-Ion Concentration; D008930:Mitochondria, Liver / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D008931:Mitochondria, Muscle / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D011188:Potassium / Q000032:analysis / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000032:analysis; D013566:Sympathomimetics / Q000494:pharmacology; D013748:Tetracaine / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000227:Adenine Nucleotides; D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000963:Antimetabolites; D013566:Sympathomimetics; D014665:Vasodilator Agents; D013748:Tetracaine; D012964:Sodium; D011433:Propranolol; D011802:Quinidine; D011188:Potassium; D002118:Calcium